1An overview of nonclinical study and evaluation of diagnostic radiopharmaceuticals approved for marketing in the United States in the last two decadesLI Ai-fang, GUANG Hong-mei, WANG Qing-li865-8702Consideration on key points of clinical trials for advanced renal cell carcinoma in ChinaXIA Lin, SONG Yuan-yuan, HAO Rui-min, YANG Zhi-min871-8753Research progress in viral clearance validation strategy of recombinant biological productsSAI Wen-bo, YU Peng-li, LI Xiao-jing, WEI Wei876-8794Introduction and interpretation of USP〈1207〉package integrity evaluation for sterile productsGUO Di-liang, DONG Wu-jun, MA Jun-wei, WANG Lu, LI Zhong-jie880-8855Considerations for the bioequivalence study of oral antitumor genericsLIU Fei-fei, YANG Jin-bo, WANG Yu-zhu886-8926Overview of the nonclinical study and evaluation of therapeutic drugs for transthyretin amyloidosis diseaseLI Ai-fang, GUANG Hong-mei, WANG Qing-li893-8977Investigation and considerations about clinical position and effect evaluation system and criterion suited for traditional Chinese medicineSONG Cai-mei, LIU Bing-lin, XUE Fei-ran, HAN Ling898-9018Some opinions about analytical method validation in drug research and developmentLI Fei, LI Yun902-9049Global approved new drugs in 2020:retrospect and prospectWU Meng, SUN You-song, CHEN Qian, YANG Zhen-zheng, ZHENG Xiao-nan905-91410Analysis of technological innovation of traditional Chinese medicine in universities of China from the perspective of patentSUN Chuan-liang, SUN Li-bing915-92011Preparation of monoclonal antibodies against fHBP and its application in determination of antigen content by ELISASU Gui-min, JI Ying, JI Guo-cun, LONG Jing, GUO Tong, SHEN Wei-jia, ZHANG Yu, ZHU Wei-hua, DU Lin921-92812New progress in research on drugs for treatment of hyperuricemiaZHOU Qi-meng, ZHAO Xiao-yue, LIANG Yu, KONG De-wen, ZHANG Sen, ZHANG Wen, SONG Jun-ke, DU Guan-hua929-93613The quality control strategy based on process analytical technology in continuous manufacturing of solid dosage formsZOU Wen-bo, ZHOU Gui-qin, LUO Su-qin, YIN Li-hui937-94614Present situation analysis and suggestions for clinical trial SAE/SUSAR reports after the implementation of new edition of GCPCAO Ye, CHEN Wen-na, WU Yue-han, LIN Jing, HUA Wu, GE Jie-ying, LIANG Lin-lin, WU Xue-mei, LI Yu947-95215Optimization of preparation process of Qiwei Chanshen Capsules by Box-Behnken design-response surface method combined with G1-entropy weight method and its quality standard researchTANG Yu, ZHANG Ai-jun, LI Shuai, ZHU Hong-mei, MAO Jiu-zhou, YU Ling-ying953-960 